Holen Sie sich die Stockscreener-App
6.31
0.00%
0.00
Schlusskurs vom Vortag:
$6.31
Offen:
$6.3
24-Stunden-Volumen:
108.59K
Relative Volume:
0.13
Marktkapitalisierung:
$916.01M
Einnahmen:
$342.81M
Nettoeinkommen (Verlust:
$97.67M
KGV:
10.27
EPS:
0.6145
Netto-Cashflow:
$50.46M
1W Leistung:
-2.62%
1M Leistung:
-9.60%
6M Leistung:
-9.34%
1J Leistung:
-28.70%
1-Tages-Spanne:
$6.14
$6.35
1-Wochen-Bereich:
$6.14
$6.50
52-Wochen-Spanne:
$5.79
$9.362
Mimedx Group Inc Stock (MDXG) Company Profile
Firmenname
Mimedx Group Inc
Sektor
Branche
Telefon
(770) 651-9100
Adresse
1775 W OAK COMMONS COURT, NE, MARIETTA
Vergleichen Sie MDXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.23 | 4.83B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.70 | 416.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.70 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.38 | 357.42M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.27 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Eingeleitet | Lake Street | Buy |
| 2023-10-27 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-07-26 | Eingeleitet | Northland Capital | Outperform |
| 2021-03-19 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten
Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings - simplywall.st
Will MiMedx Group Inc. stock outperform Nasdaq indexMarket Activity Summary & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Aug Wrap: What risks investors should watch in MiMedx Group Inc. stockJuly 2025 Highlights & Real-Time Sentiment Analysis - ulpravda.ru
Can MiMedx Group Inc. stock continue upward trendDividend Hike & Daily Growth Stock Investment Tips - ulpravda.ru
MiMedx Group Inc Is Quietly Going Off: Is MDXG the Sleeper Stock You’re Sleeping On? - AD HOC NEWS
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - 富途牛牛
Institution Moves: Can MiMedx Group Inc stock continue upward trendCPI Data & Daily Market Momentum Tracking - moha.gov.vn
Harbor Capital Advisors Inc. Cuts Holdings in MiMedx Group, Inc $MDXG - MarketBeat
Northland Securities Remains a Buy on MiMedx Group (MDXG) - The Globe and Mail
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - Sahm
MiMedx Group Signs Exclusive Agreement to Distribute Regen Lab USA's RegenKit-Wound Gel in US - marketscreener.com
MiMedx (MDXG) Secures Exclusive Deal for U.S. Distribution of Re - GuruFocus
MiMedx signs exclusive U.S. distribution deal for RegenKit-Wound Gel - Investing.com
MiMedx signs exclusive U.S. distribution deal for RegenKit-Wound Gel By Investing.com - Investing.com South Africa
MiMedx Group, Inc. Partners with Regen Lab USA LLC to Distribute RegenKit®-Wound Gel in the U.S. - Quiver Quantitative
Mimedx Enters into Exclusive U.S. Distribution Agreement for Regenkit®?-Wound Gel - marketscreener.com
Value Recap: Why MiMedx Group Inc stock remains undervaluedWeekly Risk Report & Weekly Top Performers Watchlists - moha.gov.vn
Will MiMedx Group Inc. stock gain from lower inflationJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
With 47% stake, MiMedx Group, Inc. (NASDAQ:MDXG) seems to have captured institutional investors' interest - Yahoo Finance
MIMEDX reports immunomodulatory effects of placental allografts By Investing.com - Investing.com Australia
Will MiMedx Group Inc. stock deliver consistent dividendsJuly 2025 Retail & Expert Approved Momentum Ideas - Улправда
What risks investors should watch in MiMedx Group Inc. stockJuly 2025 Price Swings & Short-Term Trading Opportunity Alerts - DonanımHaber
MIMEDX reports immunomodulatory effects of placental allografts - Investing.com
MiMedx (MDXG) Highlights New Study Showcasing Immunomodulatory B - GuruFocus
MiMedx Group, Inc. Announces New Research Supporting Immunomodulatory Effects of Amniotic Membrane Allografts - Quiver Quantitative
MIMEDX Announces Publication in the Journal of Inflammation - GlobeNewswire
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro - Sahm
Lab study finds placental tissue grafts may help reset wound healing - Stock Titan
Fundamentals Check: Can MiMedx Group Inc. stock maintain operating margins2025 Analyst Calls & Fast Entry Momentum Trade Alerts - ulpravda.ru
Can MiMedx Group Inc. stock maintain operating marginsSell Signal & Growth Oriented Trading Recommendations - Улправда
Mizuho Maintains MiMedx Group (MDXG) Outperform Recommendation - Nasdaq
MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $10.00 at Mizuho - MarketBeat
MiMedx price target lowered to $10 from $12 at Mizuho - TipRanks
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), MiMedx Group (MDXG) - The Globe and Mail
Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st
MiMedx Group Builds Momentum In Wound Care And Surgical Applications - RTTNews
Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why MiMedx Group Inc. stock remains undervaluedWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
How currency fluctuations impact MiMedx Group Inc. stockJuly 2025 Rallies & Intraday High Probability Alerts - Newser
Geode Capital Management LLC Decreases Stock Holdings in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx announces publication of interim results from CAMPAIGN trial - MSN
MiMedx Group Inc. Reports Record Q3 Revenue - MSN
MiMedx Group (MDXG) Is Down 8.4% After Strong CAMPAIGN Trial Results for EPIEFFECT Product – What's Changed - simplywall.st
MiMedx Group (MDXG) Is Down 8.4% After EPIEFFECT’s Strong Interim Trial Data Outshines Standard Care - Yahoo Finance
Is MiMedx Group Inc. stock attractive for long term wealth building - newser.com
Is MiMedx Group Inc. stock a good choice for value investors2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com
Will MiMedx Group Inc. stock maintain dividend yieldFed Meeting & Smart Money Movement Tracker - newser.com
Can MiMedx Group Inc. stock sustain market leadershipJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Finanzdaten der Mimedx Group Inc-Aktie (MDXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):